Dronabinol Pill

Phase 2Small molecule

UUniversity of Colorado, Denver

Dronabinol Pill is one of 3 small molecule programs targeting Alcohol Consumption. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Alcohol ConsumptionRecruiting

Alcohol ConsumptionPhase 2

Recruiting

Competition

Competitive Landscape

2 competitors in Alcohol Consumption

#DrugCompanyPhaseTrials

Dronabinol Pill

UUniversity of Colorado, Denver

Phase 2

1 2

Hezkue

AAspargo Labs, Inc

Phase 1

1 3

Mavoglurant

YYale University

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Alcohol Consumption1 trial

Effects of THC on Alcohol Consumption and Neural Correlates of Reward

Recruiting·UUniversity of Colorado, Denver·Phase 2·NCT06446479·28 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dronabinol Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dronabinol Pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dronabinol Pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Colorado, Denver company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Colorado, Denver

Dronabinol Pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Alcohol Consumption1 trial

References

Drug Info

Quick Facts

Related News